TherapeuticsMD, Inc. Underwriting Agreements
12 Contracts & Agreements
- Underwriting Agreement, dated February 11, 2021, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on February 16, 2021)
- Underwriting Agreement, dated November 10, 2020, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on November 13, 2020)
- Underwriting Agreement, dated October 24, 2019, by and between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters named therein (Filed With SEC on October 29, 2019)
- Underwriting Agreement, dated August 1, 2018, by and between the Company and Goldman Sachs & Co. LLC, as representative of the several underwriters named therein (Filed With SEC on August 3, 2018)
- Underwriting Agreement, dated September 25, 2017, by and between the Company and J.P. Morgan Securities LLC (Filed With SEC on September 28, 2017)
- TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on January 12, 2016)
- THERAPEUTICSMD, INC. $30,000,001.20 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on July 15, 2015)
- THERAPEUTICSMD, INC. $54,999,996.30 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on February 17, 2015)
- TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on August 4, 2014)
- 9,000,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 21, 2014)
- 13,750,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 25, 2013)
- 29,411,765 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 15, 2013)
